NCT07761949 Assessing the Impact of Streetscape Exposure on Children's Perception
| NCT ID | NCT07761949 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University |
| Condition | Myopia |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-07-02 |
| Primary Completion | 2026-07-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-07-02 with a primary completion date of 2026-07-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is to determine how streetscape exposure influences children's visual perception and psychological perception. The secondary aim is to identify streetscape elements associated with both visual and psychological perception, thereby providing evidence for environmental interventions in urban planning and public health.
Eligibility Criteria
Inclusion Criteria: \- 1: Myopia group: (1) informed consent obtained; (2) children aged 6-18 years; (3) no contraindications for wearing the eye-tracker (e.g., high astigmatism, head/neck injury); (4) myopia already present in at least one eye (spherical equivalent ≤ -0.50 D). 2: Emmetropia group: (1) informed consent obtained; (2) children aged 6-18 years; (3) no contraindications for wearing the eye-tracker (e.g., high astigmatism, head/neck injury). Exclusion Criteria: \- 1: Myopia group: (1) high myopia in either eye (spherical equivalent ≤ -6.00 D); (2) any ocular pathology other than myopia (strabismus, amblyopia, congenital cataract, juvenile glaucoma, retinal disease, etc.); (3) systemic disorders that may affect vision or visual development (e.g., diabetes); (4) anisometropia \> 1.00 D or astigmatism \> 2.00 D in either eye. 2: Emmetropia group: (1) myopia or hyperopia in either eye (spherical equivalent ≤ -0.50 D or ≥ +0.50 D); (2) any ocular pathology (strabismus, amblyopia, congenital cataract, juvenile glaucoma, retinal disease, etc.); (3) systemic disorders that may affect vision or visual development (e.g., diabetes); (4) anisometropia \> 1.00 D or astigmatism \> 2.00 D in either eye.
Frequently Asked Questions
Who can join the NCT07761949 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 18 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07761949 currently recruiting?
Yes, NCT07761949 is actively recruiting participants. Visit ClinicalTrials.gov or contact Zhongshan Ophthalmic Center, Sun Yat-sen University to inquire about joining.
Where is the NCT07761949 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT07761949 clinical trial?
NCT07761949 is sponsored by Zhongshan Ophthalmic Center, Sun Yat-sen University. The trial plans to enroll 300 participants.